The immunogenicity of an extended dosing interval of BNT162b2 against SARS-CoV-2 Omicron variant among healthy school-aged children, a randomized controlled trial.

Napaporn Chantasrisawad,Chonnamet Techasaensiri,Pope Kosalaraksa,Wanatpreeya Phongsamart,Auchara Tangsathapornpong,Peera Jaru-Ampornpan,Jiratchaya Sophonphan,Piyarat Suntarattiwong,Thanyawee Puthanakit

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases（2023）

引用 1|浏览6

暂无评分

摘要

The extended 8-week interval regimen of BNT162b2 induced higher neutralizing antibodies than a standard 3-week interval regimen. The third dose induced high neutralizing antibodies against the Omicron variant.

查看译文

关键词

Antibody,BNT162b2,COVID-19 vaccine,Children,Dosing interval,SARS-CoV-2

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要